Amid bleak outlook, antibiotic shines | Science News



Support credible science journalism.

Subscribe to Science News today.


Amid bleak outlook, antibiotic shines

12:14pm, September 30, 2003

From Chicago, at the Interscience Conference on Antimicrobial Agents and Chemotherapy

Research on a novel antibiotic offers a rare dose of optimism as existing microbe-killing compounds are losing effectiveness and the pipeline of new antibiotics is drying up.

Injections of the compound called PTK 0796 kept mice alive after they had been infected with otherwise lethal doses of Streptococcus pneumoniae, the inventors' of the drug report. In one experiment, all mice treated with at least 0.5 milligrams of the drug per kilogram of bodyweight survived infection. By comparison, only half of animals treated with similar concentrations of another antibiotic, minocycline, survived infection, say S. Ken Tanaka and his colleagues at Boston-based Paratek Pharmaceuticals.

This article is available only to subscribing members. Join the Society today or Log in.

Get Science News headlines by e-mail.

More from Science News

From the Nature Index Paid Content